Skip to main content

Journal of Gynecologic Oncology

Korean Society of Gynecologic Oncology · KR · ISSN 20050380

SJR Q1Open accessDOAJ

What the numbers say

Per-paper citedness has softened while the journal publishes a bit more.

Field-weighted citation impact moved from 2.37 to 1.93. Expect somewhat lower average citation reach for new items compared with before. The share of top-10% cited papers moved from 37.4% to 19.7%. Fewer articles now land among the field's most-cited, so high-citation placement is less common. Cervical Cancer and HPV Research rose from 5.6% to 10.4% of what the journal runs. If your work is on cervical cancer or HPV, the journal is publishing more of that area. Authors from CN went from 25.7% to 31.8%. Submissions from China are becoming a larger share of the content, so regional representation is shifting.

Citation metrics

SJR quartile
Q1
SJR score
1.26
Citations / doc (2y)
3.81
h-index
69

Based on the Scopus and OpenAlex citation graphs. We do not provide Clarivate’s JCR Impact Factor.

Output and citation impact

Whether citation performance keeps up as output grows.

PapersField-weighted impact
2018
115
2.37
2019
119
2.41
2020
79
1.57
2021
94
1.56
2022
92
1.68
2023
97
2.78
2024
129
2.16
2025
132
1.93

Topic shift

Share in the last 24 months (2024-09 – 2026-08) versus the previous 24 (2022-09 – 2024-08).

Rising
  • Cervical Cancer and HPV Research5.6%10.4%+4.9%p
    Prev
    Now
  • Ovarian cancer diagnosis and treatment18.8%23.4%+4.6%p
    Prev
    Now
Falling
  • Endometrial and Cervical Cancer Treatments46.2%40.8%−5.4%p
    Prev
    Now

Terms appearing more often

Wording in recent paper titles that stands out against the journal's own baseline.

asgokgogfigoendometrialdebulkingovariancervicalvulvar

Author countries

Last 24 months (2024-09 – 2026-08) against the previous 24 (2022-09 – 2024-08).

  • CN25.7%31.8%+6.1%p
    Prev
    Now
  • JP21.7%22.0%+0.2%p
    Prev
    Now
  • KR24.1%20.8%−3.3%p
    Prev
    Now
  • US15.0%10.2%−4.8%p
    Prev
    Now
  • TW4.7%5.1%+0.4%p
    Prev
    Now
  • TH0.0%4.3%+4.3%p
    Prev
    Now

Top 5 institutions

Top 5 institutions publishing in this journal, 2018 – 2026.

Recently published

20

The 20 most recent papers — not the full list.

1
Article2026
Clinical application value of the updated FIGO 2023 classification compared with FIGO 2009 for endometrial cancer staging in a Chinese cohort
Xiaoyan Zhao*, Lili Sun, Fujing Sun, Yushui Liu, Xi Zhang, Yanmei Zhu
OAObstetrics and GynecologyMedicine
2
Article2026
Major clinical advances in gynecologic cancer in 2025: from de-escalation strategies to precision therapies beyond <i>BRCA</i>
Lee Sung Jong*, Ji Geun Yoo, Jin Hwi Kim, Mais Mohammed I Alhulwah, Emad Ali Y Jabrah, Jeong-Yeol Park, Jongin Lee, Yoo-Young Lee, D. Suh
OAReproductive MedicineMedicine
3
Article2026
Direct comparison of 5-aminolevulinic acid photodynamic diagnosis and white light inspection for detecting peritoneal dissemination in advanced ovarian cancer: a pilot study
Akira Yabuno, Daisuke Shintani, Masakazu Sato, Sho Sato, Masanori Yasuda, Kosei Hasegawa
OAPulmonary and Respiratory MedicineMedicine
4
Article2026
External validation of the SUCCOR Risk score for predicting recurrence in early-stage cervical cancer patients treated with radical hysterectomy
Chayanid Detwongya, Charuwan Tantipalakorn, Kittipat Charoenkwan
OAObstetrics and GynecologyMedicine
5
Article2026
Prognostic outcomes in patients of low-grade endometrioid carcinoma confined to the adnexa who received no adjuvant therapy: a retrospective analysis
Xiaoyan Zhao, Shuilian Yao, Nankun Leng, Fujing Sun, Xin Zhang, Y L Zhu
OAObstetrics and GynecologyMedicine
6
Article2026
Tubal epithelial alterations: evolving concepts
Kei Koyama, Daichi Maeda, Akiteru Goto
OAObstetrics and GynecologyMedicine
7
Article2026
Enhanced ovarian cancer diagnosis using deep learning on pelvic ultrasound with integrated clinical data: retrospective multicenter study
Sohyeon Jeong, Hyewon Cho, Jooyeon Kim, Sanghoon Lee, JY Song, Jin Hwa Hong, Jae Kwan Lee, Seon Kyung Kim, Hyun-Woong Cho
OAReproductive MedicineMedicine
8
Article2026
Possible overestimation of treatment effects of pelvic and para-aortic lymphadenectomy for early-stage ovarian clear cell carcinoma: a retrospective propensity-score weighted multi-center cohort study
Naoki Horikawa*, Yoshihide Inayama, Miki Otsuki, Kota Yamauchi, Saya Kiyoshige, Yukiko Taga, Kazuki Yamano, Maki Umemiya, Motonori Matsubara, Yukio Yamanishi, Takahito Ashihara, Ikuko Emoto, M MANDAI, Ken Yamaguchi
OAReproductive MedicineMedicine
9
Article2026
Validation of molecular classification on diagnostic biopsy in endometrial carcinoma: the first step for a tailored approach
Giulia Spagnol, Matteo Marchetti, Tommaso Vezzaro, Eleonora Panizzolo, Sofia Bigardi, Orazio De Tommasi, Angela Guerriero, Lara Alessandrini, Marco Noventa, Roberto Tozzi, Carlo Saccardi
OAObstetrics and GynecologyMedicine
10
Article2026
One more opportunity in early-stage cervical cancer: the role of photodynamic therapy in managing positive surgical margins
Alexander Dushkin, T. G. Grishacheva, Stanislav Afanasiev, Irina Dushkina, Akmaral Khangeldi, Alexander Karaulov, Maxim Afanasyev
OAObstetrics and GynecologyMedicine
11
Article2026
Chemotherapy plus camrelizumab for fertility preservation (NACI-F) in FIGO stage IB1 cervical cancer: a multicenter, single-arm, phase 2 trial
Yingjie Hu, Shuting Chen, Hanxu Cheng, Yingyan Han, Chaoyang Sun, Gang Chen, Jing Chen, Kezhen Li
OAObstetrics and GynecologyMedicine
12
Article2026
Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancer
Laura Chambers*, Julia Chalif, M. Yao, Ofer Reizes, P ROSE, Chad M. Michener, Roberto Vargas
OAReproductive MedicineMedicine
15
Article2026
Development of an homologous recombination deficiency scoring algorithm for unmatched ovarian tumor sample based on next-generation sequencing
Zhizhong Wang, XinXin Yang, Taoran Cheng, Junnan Feng, Jinxiang Zheng, T. T. Wang, Mingye Zhang, H. Meng, Cai Jiang, Bing Wei
OAOncologyMedicine
16
Article2026
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results
Young Kwang Chae, Josie Czeskleba, Sandip Pravin Patel, Alex Mentor, William Robinson, Nathaniel Jones, Murtuza Rampurwala, Aung Naing, Joseph M. Beck, Carolyn Moloney-Lineen, Liam Il‐Young Chung, Christine M. McLeod, Helen Y. Chen, Elad Sharon, Sara Threlkel, Megan Othus, Christopher W. Ryan, Charles D. Blanke, R. Kurzrock
OAOncologyMedicine
17
Article2026
Evolving epidemiology and prognostic impact of young age in endometrial cancer: a multicenter retrospective study
Yaoyuan Cui, Yu Fu, Gang Chen, Chaoyang Sun
OAObstetrics and GynecologyMedicine
19
Article2026
Hokkaido phase II study of photo-immunotherapy combination with ASP-1929 for recurrent or persistent EGFR-positive vulvar, vaginal, and cervical cancers not amenable to further radiotherapy (HICARi study)
Hiroshi Asano, Hiroyuki Yamazaki, Hiroko Matsumiya, Isao Yokota, Kazufumi Okada, Ryutaro Yamamoto, Kanako C. Hatanaka, Yuko Sasajima, Michiko Nagamine, Yutaka Hatanaka, Fumi Kato, Junko Takahama, Takahiro Tsuboyama, Yudai Watanabe, Naoko Okita, Hidemichi Watari
OAPulmonary and Respiratory MedicineMedicine
20
Article2026
The effectiveness of a 3-dimensional printed vaginal dilator in mitigating radiation-induced vaginal stenosis for patients with cervical cancer
Sirikorn Kongwattanakul*, Petcharat Petroch, Kampheang Nimjaroen, Sarinya Bawornpatarapakorn, Kanyanee Laebua, Danupon Nantajit
OASurgeryMedicine

Most cited

20

Top 20 most cited, 2018 – 2026.

1
ArticleCitations 2232023
FIGO staging of endometrial cancer: 2023
Jonathan S. Berek*, Xavier Matías‐Guiu, Carien L. Creutzberg, Christina Fotopoulou, David K. Gaffney, Sean Kehoe, Kristina Lindemann, David G. Mutch, Nicole Concin
OAObstetrics and GynecologyMedicine
2
ArticleCitations 1912018
LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p
Xiaotian Luan*, Yankui Wang
OACancer ResearchBiochemistry, Genetics and Molecular Biology
3
ReviewCitations 1592018
Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
Shanshan Li, Jing Ma, Alice S.T. Wong
OACancer ResearchBiochemistry, Genetics and Molecular Biology
4
ReviewCitations 1392019
Immunotherapy in endometrial cancer: new scenarios on the horizon
Chiara Di Tucci, Carmela Capone, Giulia Galati, Valentina Iacobelli, Michele Carlo Schiavi, Violante Di Donato, Ludovico Muzii, Pierluigi Benedetti Panici
OAObstetrics and GynecologyMedicine
5
ArticleCitations 1252019
Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer
Hiroyuki Kanao*, Koji Matsuo, Yoichi Aoki, Terumi Tanigawa, Hidetaka Nomura, Sanshiro Okamoto, Nobuhiro Takeshima
OAObstetrics and GynecologyMedicine
6
ArticleCitations 1182018
Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
Myong Cheol Lim, Young‐Joo Won, Mun Jung Ko, Miseon Kim, Seung‐Hyuk Shim, Dong Hoon Suh, Jae‐Weon Kim
OAObstetrics and GynecologyMedicine
8
ArticleCitations 1162019
Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
Wataru Yamagami*, Mikio Mikami, Satoru Nagase, Tsutomu Tabata, Yoichi Kobayashi, Masanori Kaneuchi, Hiroaki Kobayashi, Hidekazu Yamada, Kiyoshi Hasegawa, Hiroyuki Fujiwara, Hidetaka Katabuchi, Daisuke Aoki
OAObstetrics and GynecologyMedicine
9
ArticleCitations 992020
National screening programs for cervical cancer in Asian countries
Eiko Saitoh*, Rutie Yin, Kemin Li, Neerja Bhatla, Seema Singhal, Dwiana Ocviyanti, Kumiko Saika, Mina Suh, Miseon Kim, Wichai Termrungruanglert
OAEpidemiologyMedicine
10
ArticleCitations 942020
Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells
Yanwei Luo*, Rong Gui
OAMolecular BiologyBiochemistry, Genetics and Molecular Biology
11
ArticleCitations 882021
Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer
Lucia Tortorella*, Stefano Restaino, Gian Franco Zannoni, Giuseppe Vizzielli, Vito Chiàntera, Serena Cappuccio, Alessandro Gioè, Eleonora La Fera, Giorgia Dinoi, Giuseppe Angelico, Giovanni Scambia, Francesco Fanfani
OAObstetrics and GynecologyMedicine
12
ArticleCitations 882019
A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial
Siriwan Tangjitgamol*, Ekkasit Tharavichitkul, Chokaew Tovanabutra, Kanisa Rongsriyam, Tussawan Asakij, Kannika Paengchit, Jirasak Sukhaboon, Somkit Penpattanagul, Lieutenant Col. Apiradee Kridakara, Jitti Hanprasertpong, Kittisak Chomprasert, Sirentra Wanglikitkoon, Thiti Atjimakul, Piyawan Pariyawateekul, Kanyarat Katanyoo, Prapai Tanprasert, Wanwipa Janweerachai, Duangjai Sangthawan, Jakkapan Khunnarong, Taywin Chottetanaprasith, Busaba Supawattanabodee, Prasert Lertsanguansinchai, Jatupol Srisomboon, Wanrudee Isaranuwatchai, V. Lorvidhaya
OAObstetrics and GynecologyMedicine
13
ArticleCitations 862019
Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
Akira Mitsuhashi, Yuji Habu, Tatsuya Kobayashi, Yoshimasa Kawarai, Hiroshi Ishikawa, Hirokazu Usui, Makio Shozu
OAObstetrics and GynecologyMedicine
14
ArticleCitations 822018
Knowledge, attitude, practice and barriers of cervical cancer screening among women living in mid-western rural, Nepal
Niresh Thapa*, Muna Maharjan, Marcia A. Petrini, Rajiv Shah, Swati Shah, Narayani Maharjan, Shrestha Navin, Hongbing Cai
OAEpidemiologyMedicine
15
ArticleCitations 792019
Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods
E Sun Paik*, Jeong‐Won Lee, Jeong‐Yeol Park, Ju-Hyun Kim, Mijung Kim, Tae‐Joong Kim, Chel Hun Choi, Byoung‐Gie Kim, Duk‐Soo Bae, Sung Wook Seo
OAReproductive MedicineMedicine
16
ArticleCitations 752019
Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
Umberto Leone Roberti Maggiore*, Fabio Martinelli, Giulia Dondi, Giorgio Bogani, Valentina Chiappa, Maria Teresa Evangelista, Viola Liberale, Antonino Ditto, Simone Ferrero, Francesco Raspagliesi
OAObstetrics and GynecologyMedicine
17
ArticleCitations 742018
Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Yong‐Man Kim*, Shin‐Wha Lee, Young-Jae Lee, Ha-Young Lee, Jong-Eun Lee, Eun-Kyung Choi
OACancer ResearchBiochemistry, Genetics and Molecular Biology
18
ArticleCitations 732018
Trends of uterine carcinosarcoma in the United States
Koji Matsuo*, Malcolm S. Ross, Hiroko Machida, Erin A. Blake, Lynda D. Roman
OAObstetrics and GynecologyMedicine
19
ArticleCitations 712018
Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
Wataru Yamagami*, Nobuyuki Susumu, Takeshi Makabe, Kensuke Sakai, Hiroyuki Nomura, Fumio Kataoka, Akira Hirasawa, Kouji Banno, Daisuke Aoki
OAObstetrics and GynecologyMedicine
20
ArticleCitations 692018
Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients
Bingyi Yang, Liying Xie, Hongwei Zhang, Qin Zhu, Yan Du, Xuezhen Luo, Xiaojun Chen
OAObstetrics and GynecologyMedicine

Similar journals

Check your draft against this journal

Start free with Nubint AI — citation checks and a peer-review simulation.

Data as of 2026-09-05